Combined impact of myosteatosis and liver steatosis on prognosis in stage I-III colorectal cancer patients.

Dong Hee LeeIl JoHye Sun LeeJeong Hyun Kang

Published in: Journal of cachexia, sarcopenia and muscle (2023)

Myosteatosis was associated with poorer survival, while the presence of LS was linked to a better prognosis in non-metastatic CRC patients. Simultaneously considering fat infiltration can serve as a more effective prognosticator in non-metastatic CRC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
squamous cell carcinoma
chronic kidney disease
small cell lung cancer
prognostic factors
peritoneal dialysis
patient reported outcomes
metabolic syndrome
patient reported